Healthcare -
Biotechnology - NASDAQ - US
$ 1.5049
13.2 %
$ 106 M
Market Cap
-2.25
P/E
SLS - TOTAL EQUITY
Total Equity SLS - SELLAS Life Sciences Group, Inc.
-7.98 M
LAST VALUE
-17.98%
2 YEAR CAGR
-20.31%
5 YEAR CAGR
-8.94%
10 YEAR CAGR